Bausch Health Companies Inc (BHC) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.835x

Based on the latest financial reports, Bausch Health Companies Inc (BHC) has a cash flow conversion efficiency ratio of -0.835x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$670.00 Million ≈ $484.67 Million USD) by net assets (CA$-802.00 Million ≈ $-580.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bausch Health Companies Inc (BHC) market capitalisation for the company's overall valuation and market capitalisation.

Bausch Health Companies Inc - Cash Flow Conversion Efficiency Trend (1993–2025)

This chart illustrates how Bausch Health Companies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bausch Health Companies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bausch Health Companies Inc ranked by their cash flow conversion efficiency. Explore Bausch Health Companies Inc cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Transportadora de Gas del Sur SA ADR
NYSE:TGS
0.045x
Construcciones y Auxiliar de Ferrocarriles S.A.
MC:CAF
0.141x
BIEM.L .FDLKK Garment Co Ltd
SHE:002832
0.029x
Henan Yuguang Gold & Lead Co Ltd
SHG:600531
-0.135x
IHS HOLDING LTD. DL-3
F:4JB
N/A
ARMOUR Residential REIT Inc
NYSE:ARR
0.081x
Autohome Inc ADR
F:8AHB
N/A
Cadeler As
OL:CADLR
0.148x

Annual Cash Flow Conversion Efficiency for Bausch Health Companies Inc (1993–2025)

The table below shows the annual cash flow conversion efficiency of Bausch Health Companies Inc from 1993 to 2025. View BHC stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$376.31 Million
≈ $272.22 Million
CA$1.38 Billion
≈ $997.34 Million
3.664x +173.87%
2024-12-31 CA$-322.00 Million
≈ $-232.93 Million
CA$1.60 Billion
≈ $1.16 Billion
-4.960x +60.59%
2023-12-31 CA$-82.00 Million
≈ $-59.32 Million
CA$1.03 Billion
≈ $746.53 Million
-12.585x -349.48%
2022-12-31 CA$260.00 Million
≈ $188.08 Million
CA$-728.00 Million
≈ $-526.62 Million
-2.800x +93.32%
2021-12-31 CA$-34.00 Million
≈ $-24.60 Million
CA$1.43 Billion
≈ $1.03 Billion
-41.941x -2383.93%
2020-12-31 CA$605.00 Million
≈ $437.65 Million
CA$1.11 Billion
≈ $803.68 Million
1.836x +38.98%
2019-12-31 CA$1.14 Billion
≈ $821.77 Million
CA$1.50 Billion
≈ $1.09 Billion
1.321x +147.80%
2018-12-31 CA$2.81 Billion
≈ $2.04 Billion
CA$1.50 Billion
≈ $1.09 Billion
0.533x +38.40%
2017-12-31 CA$5.94 Billion
≈ $4.30 Billion
CA$2.29 Billion
≈ $1.66 Billion
0.385x -39.86%
2016-12-31 CA$3.26 Billion
≈ $2.36 Billion
CA$2.09 Billion
≈ $1.51 Billion
0.641x +75.54%
2015-12-31 CA$6.03 Billion
≈ $4.36 Billion
CA$2.20 Billion
≈ $1.59 Billion
0.365x -13.58%
2014-12-31 CA$5.43 Billion
≈ $3.93 Billion
CA$2.29 Billion
≈ $1.66 Billion
0.422x +112.08%
2013-12-31 CA$5.23 Billion
≈ $3.79 Billion
CA$1.04 Billion
≈ $753.74 Million
0.199x +12.73%
2012-12-31 CA$3.72 Billion
≈ $2.69 Billion
CA$656.58 Million
≈ $474.96 Million
0.177x +4.62%
2011-12-31 CA$4.01 Billion
≈ $2.90 Billion
CA$676.47 Million
≈ $489.35 Million
0.169x +215.02%
2010-12-31 CA$4.91 Billion
≈ $3.55 Billion
CA$263.19 Million
≈ $190.39 Million
0.054x -79.89%
2009-12-31 CA$1.35 Billion
≈ $979.73 Million
CA$360.90 Million
≈ $261.07 Million
0.266x +56.71%
2008-12-31 CA$1.20 Billion
≈ $869.22 Million
CA$204.32 Million
≈ $147.81 Million
0.170x -35.25%
2007-12-31 CA$1.30 Billion
≈ $938.82 Million
CA$340.85 Million
≈ $246.57 Million
0.263x -35.35%
2006-12-31 CA$1.28 Billion
≈ $929.45 Million
CA$521.93 Million
≈ $377.56 Million
0.406x +12.50%
2005-12-31 CA$1.38 Billion
≈ $997.94 Million
CA$498.11 Million
≈ $360.32 Million
0.361x +77.00%
2004-12-31 CA$1.36 Billion
≈ $982.59 Million
CA$277.09 Million
≈ $200.44 Million
0.204x -36.22%
2003-12-31 CA$881.60 Million
≈ $637.73 Million
CA$281.98 Million
≈ $203.98 Million
0.320x -19.04%
2002-12-31 CA$845.69 Million
≈ $611.76 Million
CA$334.10 Million
≈ $241.69 Million
0.395x +56.58%
2001-12-31 CA$1.13 Billion
≈ $814.58 Million
CA$284.12 Million
≈ $205.53 Million
0.252x -41.54%
2000-12-31 CA$237.46 Million
≈ $171.77 Million
CA$102.49 Million
≈ $74.14 Million
0.432x +131.96%
1999-12-31 CA$435.30 Million
≈ $314.89 Million
CA$81.00 Million
≈ $58.59 Million
0.186x -82.23%
1998-12-31 CA$51.20 Million
≈ $37.04 Million
CA$53.60 Million
≈ $38.77 Million
1.047x +1738.12%
1997-12-31 CA$75.50 Million
≈ $54.62 Million
CA$4.30 Million
≈ $3.11 Million
0.057x +137.53%
1996-12-31 CA$36.90 Million
≈ $26.69 Million
CA$-5.60 Million
≈ $-4.05 Million
-0.152x -107.12%
1995-12-31 CA$14.60 Million
≈ $10.56 Million
CA$31.10 Million
≈ $22.50 Million
2.130x +530.85%
1994-12-31 CA$7.70 Million
≈ $5.57 Million
CA$2.60 Million
≈ $1.88 Million
0.338x -58.19%
1993-12-31 CA$-2.60 Million
≈ $-1.88 Million
CA$-2.10 Million
≈ $-1.52 Million
0.808x --

About Bausch Health Companies Inc

TO:BHC Canada Drug Manufacturers - Specialty & Generic
Market Cap
$2.13 Billion
CA$2.95 Billion CAD
Market Cap Rank
#5925 Global
#193 in Canada
Share Price
CA$7.88
Change (1 day)
-4.48%
52-Week Range
CA$6.25 - CA$10.95
All Time High
CA$213.05
About

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmac… Read more